Artemis Medicare board meeting scheduled for May 8, 2026 to approve audited financial results for Q4 and FY26.
Board will consider recommending dividend for FY26 on equity shares during the meeting.
Trading window closure period confirmed from April 1 to May 10, 2026, encompassing results declaration.